Figure (Figure01)
Vigabatrin Tablet, Film Coated
Product Images NDC 80005-167
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vigabatrin (NDC 80005-167). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Carnegie Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure (Figure02)
Label (Image01)
This description provides guidance on the storage of Vigabatrin tablets, USP, advising to keep them at a temperature between 20° to 25°C (68° to 77°F) in a tight, light-resistant container with a child-resistant closure. The text also emphasizes the importance of keeping all drugs out of children's reach and instructs pharmacists to dispense the accompanying Medication Guide to each patient. Additionally, it lists the content of each tablet (500 mg of Vigabatrin, USP) and advises to refer to the package insert for full prescribing information. The tablets are distributed by Carnegie Pharmaceuticals LLC, based in Delran, NJ, USA, and the revision date of the information provided is 02/2026.*
Carton (Image02)
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
